Meningioma treatment in Spain — get 3 personalized clinic matches

Prof. Gerardo Conesa Bertran has performed over 1,100 neurosurgical procedures with 39 years of specialized meningioma experience. The JCI-accredited clinic offers CyberKnife robotic radiosurgery for about $19,565–$23,913 including sessions and follow-up. Minimally invasive surgical removal costs around $29,445–$34,156, which covers the procedure, anesthesia, and a 5-7 day hospital stay. Diagnostics may start from $600 for a consultation.

Hospital Quiron Barcelona specializes in advanced neurosurgical treatments for meningioma, featuring state-of-the-art technology like PET-CT and MRI for precise diagnostics. Dr. Pablo Clavel, a neurosurgeon with 20+ years of experience, leads the team, having trained at top American institutions including Emory University and the University of California. Treatment costs typically range from $4,400 to $8,900.

Quirónsalud Madrid specializes in neurosurgery for meningioma, with treatment costs typically ranging from $5,100 to $10,500. The clinic is the largest in Spain and Europe by patient volume and conducts research on neurodegenerative disorders. Dr. Luis Madero, with 37+ years of experience, leads pediatric oncology and has authored numerous publications and chapters.

Dr. Roberto Martínez Álvarez has performed 1,100+ radiosurgery procedures across a 40-year career and sits on the ISRS Executive Council. Hospital Ruber Internacional, JCI-accredited, has completed over 8,100 GammaKnife-type treatments since 1993. A consultation typically costs around $595. CyberKnife radiosurgery runs €18,000–25,000, covering treatment planning, the session, and follow-up. The Gamma Knife package for meningioma costs around $27,350–32,820.

SJD Barcelona Children's Hospital (Spain) treats patients from infancy to 18 years old. It is among the top three medical institutions in Europe and a leading center for pediatric oncology. The hospital has a dedicated Laboratory for Molecular Medicine, where innovative treatment methods are developed.